TrialInvestigational new drugs2022

Phase II study of Disulfiram and Cisplatin in Refractory Germ Cell Tumors. The GCT-SK-006 phase II trial.

M Mego et al.PubMed ↗Publisher ↗

No numbers read from the abstract.